Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study.
Jessica HowellAmit SamaniBinish MannanSaur HajievLeila Motedayen AvalRebecca AbdelmalakVincent C TamDominik BettingerRobert ThimmeTamar H TaddeiDavid E KaplanMax SeidenstickerRohini SharmaPublished in: Therapeutic advances in gastroenterology (2022)
Survival in HCC does not appear to be influenced by the presence of NAFLD. NAFLD-associated HCC derive similar clinical benefit from sorafenib compared with other aetiologies.
Keyphrases